Answers are grounded in this paper and cite their sources.
Alzheimer’s disease (AD) is increasingly recognized not only as a disorder of protein aggregation, but also as a failure of brain homeostasis, interstitial solute clearance, and gliovascular regulation. In this context, glymphatic dysfunction may contribute to amyloid-β (Aβ) and tau accumulation, neuroinflammation, and neurovascular impairment. However, current models often attribute glymphatic failure mainly to altered aquaporin-4 (AQP4)-mediated water transport at astrocytic endfeet, a view that does not fully explain the broader ionic, structural, vascular, and mechanical abnormalities observed in AD. Here, we propose that glymphatic dysfunction may be understood as a systems-level failure of mechano-ionic homeostasis at the gliovascular interface. In this model, efficient cerebrospinal fluid-interstitial fluid (CSF-ISF) exchange depends not only on water permeability, but also on extracellular space (ECS) geometry, astrocytic volume regulation, ionic gradients, tissue compliance, and neurovascular coupling. We discuss AQP4, Kir4.1, VRAC/LRRC8, TRPV4, and Piezo1 as interconnected regulators of water flux, K + buffering, osmotic balance, mechanotransduction, and inflammatory signaling. By proposing impaired gliovascular mechano-ionic integration as a potential contributor to glymphatic dysfunction, this review identifies new conceptual and therapeutic directions for investigating clearance impairment in AD.
No takes yet. Share an insight, caveat, or question.
Cipriano et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: